论文信息 - VEGF remains an interesting target in advanced pancreas cancer ( APCA ) : results of a multi-institutional phase II study of bevacizumab , gemcitabine , and infusional 5-fl uorouracil in patients with APCA - 字舞流文

VEGF remains an interesting target in advanced pancreas cancer ( APCA ) : results of a multi-institutional phase II study of bevacizumab , gemcitabine , and infusional 5-fl uorouracil in patients with APCA

M. Korc | T. Gardner | S. Gordon | G. Tsongalis | T. Mackenzie | A. Srivastava | R. Barth | A. Suriawinata | T. Colacchio | J. Sutton | B. Zaki | M. Tsapakos | G. Ripple | M. McGowan | M. Preis | K. Smith | T. H. Davis | S. M. Tarczewski | S. Tarczewski